Detalhe da pesquisa
1.
Phase 3 Safety and Efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 Vaccine.
N Engl J Med
; 385(25): 2348-2360, 2021 12 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-34587382
2.
Comparable Antigenicity and Immunogenicity of Oligomeric Forms of a Novel, Acute HIV-1 Subtype C gp145 Envelope for Use in Preclinical and Clinical Vaccine Research.
J Virol
; 89(15): 7478-93, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25972551
3.
Rapid Development of an Integrated Network Infrastructure to Conduct Phase 3 COVID-19 Vaccine Trials.
JAMA Netw Open
; 6(1): e2251974, 2023 01 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36689221
4.
Efficacy of a bivalent (D614 + B.1.351) SARS-CoV-2 Protein Vaccine.
medRxiv
; 2023 Jan 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-36523415
5.
Efficacy of a bivalent (D614 + B.1.351) SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant in adults: a phase 3, parallel, randomised, modified double-blind, placebo-controlled trial.
Lancet Respir Med
; 11(11): 975-990, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37716365
6.
Efficacy of a monovalent (D614) SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant in adults: a phase 3, multi-country study.
EClinicalMedicine
; 64: 102168, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37936652
7.
Immune correlates analysis of a phase 3 trial of the AZD1222 (ChAdOx1 nCoV-19) vaccine.
NPJ Vaccines
; 8(1): 36, 2023 Mar 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36899062
8.
Leveraging lessons learned from the COVID-19 pandemic for HIV.
Commun Med (Lond)
; 2: 110, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36045906
9.
Durability of protection and immunogenicity of AZD1222 (ChAdOx1 nCoV-19) COVID-19 vaccine over 6 months.
J Clin Invest
; 132(18)2022 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36106642
10.
Robust humoral and cellular recall responses to AZD1222 attenuate breakthrough SARS-CoV-2 infection compared to unvaccinated.
Front Immunol
; 13: 1062067, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36713413
11.
Safety and immunogenicity of an AS03-adjuvanted SARS-CoV-2 recombinant protein vaccine (CoV2 preS dTM) in healthy adults: interim findings from a phase 2, randomised, dose-finding, multicentre study.
Lancet Infect Dis
; 22(5): 636-648, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35090638
12.
Characterization of orderly spatiotemporal patterns of clock gene activation in mammalian suprachiasmatic nucleus.
Eur J Neurosci
; 33(10): 1851-65, 2011 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-21488990
13.
Workshop report: Nucleic acid delivery devices for HIV vaccines: Workshop proceedings, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, USA, May 21, 2015.
Vaccine
; 36(4): 427-437, 2018 01 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-29174315
14.
Rapid Development of an Integrated Network Infrastructure to Conduct Phase 3 COVID-19 Vaccine Trials
Artigo
em Português
| Arca: Repositório institucional da Fiocruz | ID: arc-57779